000 | 00941 a2200253 4500 | ||
---|---|---|---|
005 | 20250514054014.0 | ||
264 | 0 | _c20030403 | |
008 | 200304s 0 0 eng d | ||
022 | _a1226-0479 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTovey, Michael G | |
245 | 0 | 0 |
_aOromucosal cytokine therapy: mechanism(s) of action. _h[electronic resource] |
260 |
_bTaehan Kan Hakhoe chi = The Korean journal of hepatology _cJun 2002 |
||
300 |
_a125-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
650 | 0 | 4 |
_aHepatitis, Viral, Human _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
773 | 0 |
_tTaehan Kan Hakhoe chi = The Korean journal of hepatology _gvol. 8 _gno. 2 _gp. 125-31 |
|
999 |
_c12303358 _d12303358 |